Zobrazeno 1 - 10
of 224
pro vyhledávání: '"R.C.F. Leonard"'
Autor:
B.J. Milner, David E. Parkin, Neva E. Haites, Henry C Kitchener, A.M. Lessells, I.D. Miller, D.M. Eccles, L Allan, Marion K Campbell, R.C.F. Leonard
Publikováno v:
International Journal of Gynecological Cancer. 6:483-490
Mutation of the p53 tumor suppressor gene is the most commonly observed genetic abnormality in human tumors and associations between p53 aberration and patient survival have been shown for several tumor types. Previous studies have found that approxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48620363b3d26d9b4b2fac49e576638d
https://doi.org/10.1046/j.1525-1438.1996.06060483.x
https://doi.org/10.1046/j.1525-1438.1996.06060483.x
Publikováno v:
The Breast. 5:259-264
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::323176468749dc6603baaa8da45b88b5
https://doi.org/10.1016/s0960-9776(96)90021-1
https://doi.org/10.1016/s0960-9776(96)90021-1
Autor:
A. Cremaschi, A. Van Dalen, Petra Stieber, Rafael Molina, S. Saracchini, R.C.F. Leonard, Catharine M. Sturgeon, R. Einarsson, K.J. Heering, P. Geroni, Massimo Gion, Vivian Barak, Tamar Peretz, M. Namer
Publikováno v:
The Breast. 5:82-88
One hundred and twenty-nine patients with dissiminated breast cancer were selected to study the clinical applicability of changes in CA 15-3, tissue polypeptide specific antigen (TPS) and carcinoembryonic antigen (CEA) during therapy and how these co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c97495463e0e73400acf21978ea5746e
https://doi.org/10.1016/s0960-9776(96)90126-5
https://doi.org/10.1016/s0960-9776(96)90126-5
Publikováno v:
International Journal of Gynecologic Cancer. 2:134-140
The relatively high incidence of amplification and overexpression of the neu (c-erb B2/HER-2) oncogene in breast cancer, and its association with poor prognosis, particularly in node negative patients, may allow identification of patients who require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5500f7d3d356c39debfebaf1387d6fb2
https://doi.org/10.1046/j.1525-1438.1992.02030134.x
https://doi.org/10.1046/j.1525-1438.1992.02030134.x
Autor:
R.C.F. Leonard, R.L. Hayward, R.J. Prescott, J.-X. Wang, N.C. Allan, A. Barrett, S.N. Das, A.A. Dawson, A. Heppleston, A.M. Lessells, N.P. Lucie, H.H. Lucraft, M.J. Mackie, K.S. MacLaren, A.C. Parker, S.J. Proctor, T.K. Sarkar, T. Sheehan, M. Soukop, W.P. Steward, J.M. White
Publikováno v:
Annals of Oncology. 2:655-662
Summary A prognostic model was developed by examination of the prospectively recorded presentation characteristics of patients presenting with low grade non-Hodgkin's lymphomas (LGL). A geographically distinct group (Edinburgh and Borders) was exclud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::342ec27aa8d379e5cfc199c073317a68
https://doi.org/10.1093/oxfordjournals.annonc.a058044
https://doi.org/10.1093/oxfordjournals.annonc.a058044
Publikováno v:
Breast (Edinburgh, Scotland). 18(4)
Anthracyclines are valuable cytotoxic agents in cancer treatment. However, their usefulness is limited by cumulative dose-dependent cardiotoxicity that may manifest as life-threatening congestive heart failure. To avoid cardiotoxicity, the use of dox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9479975fff047998572f6b0d61c4d83f
https://pubmed.ncbi.nlm.nih.gov/19656681
https://pubmed.ncbi.nlm.nih.gov/19656681
Publikováno v:
Pediatric bloodcancer. 44(3)
Background Despite recommendations that adolescents should have in-patient management amongst their peers, there is little literature to support this. The study aim was to evaluate and contrast patient satisfaction for teenage cancer patients treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d160fa26f56a1b973e4a0398f2b365d7
https://pubmed.ncbi.nlm.nih.gov/15514917
https://pubmed.ncbi.nlm.nih.gov/15514917
Publikováno v:
European Journal of Cancer. 37:27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16e39d909d7e1083517cfc4d3adcef1f
https://doi.org/10.1016/s0959-8049(01)80111-8
https://doi.org/10.1016/s0959-8049(01)80111-8
Publikováno v:
European Journal of Cancer. 37:11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67d2d0c33ec93cdc941d65d31f2a9b70
https://doi.org/10.1016/s0959-8049(01)80064-2
https://doi.org/10.1016/s0959-8049(01)80064-2
Autor:
R.C.F. Leonard, S. Povey, G. McIntyre, R. Salazar, C. Twelves, A. Hutcheon, D. Bissett, T. Bates, A. Chaturvedl, S. Chan, J. Carmichael
Publikováno v:
European Journal of Cancer. 37:28
Following the encouraging results achieved with the oral fluoropyrimidine capecitabine in clinical trials, a named patient programme was initiated in the UK, through which patients with advanced breast cancer were prescribed capecitabine monotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786e41e1f145aef23a9a4f1835c3257d
https://doi.org/10.1016/s0959-8049(01)80114-3
https://doi.org/10.1016/s0959-8049(01)80114-3